Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Peringkat dalam Saham #32244
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Harga Saham
$4.65
Terakhir disinkronkan: 2024-07-24
Kapitalisasi Pasar
$10.63M
Perubahan (1 hari)
6.66%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan Medlab Clinical Limited (MDC)

Kategori

Riwayat dividen untuk Medlab Clinical Limited (MDC)
Saham Medlab Clinical Limited (simbol: MDC) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Medlab Clinical Limited (MDC) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
NL
64.00%
AU
0.00%
CH
0.00%
KR